+499.5%
MRNA vs GRMN
+18.2%
+481.3%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GRMN | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -0.1% | -2.2% | -2.2% |
| 7D | +5.5% | -2.9% | +8.3% | +6.4% |
| 30D | +158.7% | -8.4% | +167.2% | +167.2% |
| 3M | +182.1% | +15.0% | +167.1% | +158.6% |
| 6M | +151.8% | +11.2% | +140.6% | +135.9% |
| YTD | +393.6% | +37.7% | +355.9% | +295.7% |
| 1Y | +499.5% | +18.5% | +481.0% | +387.6% |
| All | +499.5% | +18.2% | +481.3% | +387.6% |
Cumulative growth
Daily Returns
Daily percentage return beside GRMN.
Daily Out/Under-Performance
Portfolio return minus GRMN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GRMN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GRMN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling